Preventing Biofilm Formation and Development on Ear, Nose and Throat Medical Devices
Overview
Affiliations
Otorhinolaryngology is a vast domain that requires the aid of many resources for optimal performance. The medical devices utilized in this branch share common problems, such as the formation of biofilms. These structured communities of microbes encased in a 3D matrix can develop antimicrobial resistance (AMR), thus making it a problem with challenging solutions. Therefore, it is of concern the introduction in the medical practice involving biomaterials for ear, nose and throat (ENT) devices, such as implants for the trachea (stents), ear (cochlear implants), and voice recovery (voice prosthetics). The surface of these materials must be biocompatible and limit the development of biofilm while still promoting regeneration. In this respect, several surface modification techniques and functionalization procedures can be utilized to facilitate the success of the implants and ensure a long time of use. On this note, this review provides information on the intricate underlying mechanisms of biofilm formation, the large specter of implants and prosthetics that are susceptible to microbial colonization and subsequently related infections. Specifically, the discussion is particularized on biofilm development on ENT devices, ways to reduce it, and recent approaches that have emerged in this field.
Ghosh Moulic A, Deshmukh P, Gaurkar S Cureus. 2024; 16(4):e57634.
PMID: 38707023 PMC: 11070220. DOI: 10.7759/cureus.57634.
Biofilms on Voice Prosthesis - Challenges and Therapeutic Insights.
Caciandone-Cringureanu M, Anghel A, Anghel I Maedica (Bucur). 2023; 18(3):498-503.
PMID: 38023755 PMC: 10674123. DOI: 10.26574/maedica.2023.18.3.498.
The biofilm characteristics and management of skin flap infection following cochlear implantation.
Chen X, Chen Y, Zhang R, Ye S, Lin Z, Nian S Acta Otorhinolaryngol Ital. 2022; 42(4):372-379.
PMID: 36254653 PMC: 9577691. DOI: 10.14639/0392-100X-N1985.
Lundin P, Fiser B, Blackledge M, Pickett H, Copeland A Pharmaceutics. 2022; 14(8).
PMID: 36015238 PMC: 9415113. DOI: 10.3390/pharmaceutics14081613.
Nguyen A, Yahyazadeh Shourabi A, Yaghoobi M, Zhang S, Simpson K, Abbaspourrad A PLoS One. 2022; 17(8):e0272294.
PMID: 35960726 PMC: 9374262. DOI: 10.1371/journal.pone.0272294.